Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 31, 2008 16:00 ET | Source: Achillion Pharmaceuticals, Inc.

New Data for Achillion's Elvucitabine Demonstrate Drug's Safety, Efficacy and Suitability for Combination Therapy in HIV-Infected Patients

NEW HAVEN, Conn., Jan. 31, 2008 (PRIME NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging...
November 26, 2007 16:05 ET | Source: Achillion Pharmaceuticals, Inc.

Achillion Announces Appointment of New Chief Medical Officer

NEW HAVEN, Conn., Nov. 26, 2007 (PRIME NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging...
November 02, 2007 16:05 ET | Source: Achillion Pharmaceuticals, Inc.

Achillion to Present At Upcoming Conferences

NEW HAVEN, Conn., Nov. 2, 2007 (PRIME NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging...
November 02, 2007 07:00 ET | Source: Achillion Pharmaceuticals, Inc.

Achillion Reports Third Quarter 2007 Financial Results

NEW HAVEN, Conn., Nov. 2, 2007 (PRIME NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging...
October 15, 2007 16:08 ET | Source: Achillion Pharmaceuticals, Inc.

Achillion Reports Safety and Potent Antiviral Activity in Topline Results From Elvucitabine Phase 2 Study in HIV-Infected Patients

NEW HAVEN, Conn., Oct. 15, 2007 (PRIME NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging...
September 17, 2007 12:13 ET | Source: Achillion Pharmaceuticals, Inc.

Achillion to Present At the First Annual Maxim Group Growth Conference

NEW HAVEN, Conn., Sept. 17, 2007 (PRIME NEWSWIRE) -- Achillion Pharmaceuticals, Inc., (Nasdaq:ACHN) a leader in the discovery and development of small molecule drugs to combat the most challenging...
August 22, 2007 16:17 ET | Source: Achillion Pharmaceuticals, Inc.

Achillion Appoints Pharmathene CEO David P. Wright to Board of Directors

NEW HAVEN, Conn., Aug. 22, 2007 (PRIME NEWSWIRE) -- Achillion Pharmaceuticals, Inc., (Nasdaq:ACHN) a leader in the discovery and development of small molecule drugs to combat the most challenging...
August 08, 2007 16:05 ET | Source: Achillion Pharmaceuticals, Inc.

Achillion Reports 2007 Second Quarter Financial Results

NEW HAVEN, Conn., Aug. 8, 2007 (PRIME NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging...
July 27, 2007 09:23 ET | Source: Achillion Pharmaceuticals, Inc.

Achillion to Host Second Quarter Investor Conference Call On August 8, 2007

NEW HAVEN, Conn., July 27, 2007 (PRIME NEWSWIRE) -- Achillion Pharmaceuticals Inc. (Nasdaq:ACHN) expects to release its results for the second quarter ended June 30, 2007 after the market closes on...
June 11, 2007 17:25 ET | Source: Achillion Pharmaceuticals, Inc.

Achillion Announces the Promotion of Milind S. Deshpande, Ph.D. to Executive Vice President of Research

NEW HAVEN, Conn., June 11, 2007 (PRIME NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging...